Variant report
Variant | esv1803439 |
---|---|
Chromosome Location | chr4:187880690-187899222 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:187759553..187761639-chr4:187893343..187896166,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112885722 | chr4:187880697-187880698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565330130 | chr4:187880698-187880699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112403487 | chr4:187880708-187880709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532506682 | chr4:187880711-187880712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565444518 | chr4:187880717-187880718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs113537675 | chr4:187880737-187880738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531234248 | chr4:187880750-187880751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113726818 | chr4:187880756-187880757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576853248 | chr4:187880757-187880758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200093335 | chr4:187880759-187880760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550634359 | chr4:187880766-187880767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377464964 | chr4:187880770-187880771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529841049 | chr4:187880774-187880775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112975677 | chr4:187880777-187880778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557472904 | chr4:187880786-187880787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546737575 | chr4:187880790-187880791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs62345062 | chr4:187880797-187880798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562636945 | chr4:187880800-187880801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188166828 | chr4:187898442-187898443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150632632 | chr4:187898454-187898455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10008450 | chr4:187898520-187898521 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs572238141 | chr4:187898540-187898541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191391156 | chr4:187898568-187898569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs376002043 | chr4:187898583-187898584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs34058005 | chr4:187898586-187898587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76315462 | chr4:187898605-187898606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568383683 | chr4:187898607-187898608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs113507739 | chr4:187898640-187898641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564581130 | chr4:187898644-187898645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112821757 | chr4:187898660-187898661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563871300 | chr4:187898691-187898692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543933726 | chr4:187898704-187898705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144389192 | chr4:187898751-187898752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs9998172 | chr4:187898773-187898774 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs74644622 | chr4:187898774-187898775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs9998173 | chr4:187898778-187898779 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs528057296 | chr4:187898786-187898787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551511855 | chr4:187898803-187898804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs59364127 | chr4:187898836-187898837 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs7672831 | chr4:187898882-187898883 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs575965596 | chr4:187898905-187898906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs59208113 | chr4:187899002-187899003 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs74321400 | chr4:187899031-187899032 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371192050 | chr4:187899099-187899100 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs139758208 | chr4:187899158-187899159 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192564608 | chr4:187899161-187899162 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76000566 | chr4:187899171-187899172 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534660950 | chr4:187899186-187899187 | Enhancers Flanking Active TSS Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149891098 | chr4:187899209-187899210 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs577714906 | chr4:187899211-187899212 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Facioscapulohumeral muscular dystrophy | 21829175 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Autism | 18414403 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 20409316 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Developmental delay | 22127048 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cervical cancer | 21063398 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Oral cancer | 17325662 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:187868400-187880800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr4:187898400-187899400 | Enhancers | Fetal Lung | lung |
3 | chr4:187898800-187899000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr4:187898800-187900000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr4:187899000-187899200 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr4:187899000-187899600 | Active TSS | NHLF | lung |
7 | chr4:187899000-187899800 | Enhancers | Osteobl | bone |
8 | chr4:187899200-187899400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |